Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.

By M. Swartz, D. Perkins, T. Scott Stroup, J. McEvoy, Jennifer M Nieri, D. Haak. 2003

102 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Psychiatry and Mental health, Philosophy

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

1. Eric B. Laber
2. Daniel J. Lizotte
3. Michael H. Bowling
4. Susan M. Shortreed
5. Susan A. Murphy
6. Ashkan Ertefaie
7. Bibhas Chakraborty
8. Joelle Pineau

In Psychiatry and Mental health

1. Eric B. Laber
2. Susan M. Shortreed
3. Daniel J. Lizotte
4. Erica E. Moodie
5. Susan A. Murphy
6. Michael H. Bowling
7. Shamim Nemati
8. Chao Yu

In Philosophy

1. Susan M. Shortreed
2. Erica E. Moodie
3. Joelle Pineau
4. Michael H. Bowling

Citations in the corpus

• Informing sequential clinical decision-making through reinforcement learning: an empirical study (2010, methodology): “As this study is described in detail elsewhere (Stroup et al. 2003; Swartz et al. 2003), we give a simplified overview of the CATIE study here.”
• Q-learning Residual Analysis: Application to The Effectiveness of Sequences of Antipsychotic Medications for Patients with Schizophrenia (2016, background): “Clinical Antipsychotic Trials of Intervention and Effectiveness (CATIE) study, a well-known SMART study that was designed to compare the effectiveness of sequences of antipsychotic medications for patients with schizophrenia [6, 9].”
• Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. (2005, unknown): “Risperidone alone 57 (17) 59 (18) 63 (18) 64 (25) 32 (17) 275 (19)”
• A national study of violent behavior in persons with schizophrenia. (2006, methodology): “Baseline assessments were conducted during a 1-time structured interview by trained clinical interviewers blind to random assignment for the subsequent follow-up study.(4,19)”
• Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. (2007, unknown): “Never married 489 (60) 287 (57) 177 (60)”
• Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. (2006, unknown): “05, clozapine was then compared with each of the other atypical antipsychotics with a Hochberg adjustment for multiple comparisons (12), in which the largest p value was compared to 0.”
• Linear Fitted-Q Iteration with Multiple Reward Functions (2012, methodology): “The full study design is quite complex (Stroup et al., 2003; Swartz et al., 2003); we have therefore chosen a simplified subset of the CATIE data in order to more clearly illustrate the potential of the methods presented in this paper.”
• Estimating the optimal dynamic antipsychotic treatment regime: Evidence from the sequential multiple assignment randomized CATIE Schizophrenia Study (2012, methodology): “The details of the design and protocol of the CATIE study have been described in detail elsewhere (Swartz et al., 2003; Stroup et al., 2003, 2006; Lieberman et al., 2005; McEvoy et al., 2006); thus, here we give a brief review of the CATIE study as it pertains to the scientific question of interest…”